tiprankstipranks
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market
RXRX
Recursion Pharmaceuticals
RESEARCH TOOLSreports
Want to see RXRX full AI Analyst Report?

Recursion Pharmaceuticals (RXRX) Income Statement

4,434 Followers

Recursion Pharmaceuticals Income Statement

Last quarter (Q4 2025), Recursion Pharmaceuticals's total revenue was $35.54M, an increase of 687.81% from the same quarter last year. In Q4, Recursion Pharmaceuticals's net income was $-108.12M. See Recursion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 74.68M$ 58.84M$ 43.88M$ 39.68M$ 10.00M
Gross Profit
$ -46.27M$ 13.60M$ 1.29M$ -8.59M$ 10.00M
Operating Expenses
$ 601.86M$ 492.61M$ 351.35M$ 237.13M$ 192.78M
Depreciation and Amortization
$ 83.70M$ 36.49M$ 24.40M$ 11.76M$ 8.40M
EBITDA
$ -559.38M$ -426.72M$ -307.63M$ -227.66M$ -175.12M
Operating Income
$ -648.13M$ -479.00M$ -350.06M$ -245.73M$ -182.78M
Other Income/Expenses
$ 3.24M$ 14.22M$ 17.93M$ 6.25M$ -3.70M
Pretax Income
$ -644.89M$ -464.79M$ -332.13M$ -239.48M$ -186.48M
Net Income
$ -644.76M$ -463.66M$ -328.07M$ -239.48M$ -186.48M
Per Share Metrics
Basic EPS
$ -1.44$ -1.69$ -1.58$ -1.36$ -1.05
Diluted EPS
$ -1.44$ -1.69$ -1.58$ -1.36$ -1.05
Weighted Average Shares Outstanding
 447.45M 274.21M 207.85M 175.54M 170.27M
Weighted Average Shares Outstanding (Diluted)
 447.45M 274.21M 207.85M 175.54M 170.27M
Currency in USD

Recursion Pharmaceuticals Earnings and Revenue History